Product Profiles

Article

A round up of new products

Combined platform

Available from Oertli is its combined platform, the faros, which has been designed to enable surgeons to work on both the anterior and posterior segments of the eye. It is also available as a pure phaco machine with permanent upgrade options for the posterior segment.

For more detailed information on this instrument visit http://www.oertli-faros.com/ and http://www.oertli-instruments.com/

Femtosecond laser procedures

The CUSTOMLENS laser performs anterior capsulotomy, lens fragmentation, and corneal incision and also features an on-line optical coherence tomography, providing a real-time view of the procedure. A standalone laser for cataract surgery will also be available.

The SUPRACOR excimer laser is an aberration-optimized presbyopic algorithm and can be used for the treatment of hyperopia, emmetropia and myopia. The same treatment profile is applied to both eyes and the procedure is suitable for post-LASIK eyes.

For more information please visit http://www.technolaspv.com/

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.